Finance

Lists
NX1:ASX
Nexalis Therapeutics Ltd
0,015 A$
0,00%
(0,00) 1D
25 қыр., 11:49:24 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NX1...
Mkt. cap
3,80 млн
Avg. vol.
76,09 мың
Volume
0,00
52-wk high
0,03 A$
52-wk low
0,01 A$
EPS
-0,01 A$
Shares outstanding
253,04 млн
Mkt. cap
3,80 млн
Avg. vol.
76,09 мың
Volume
0,00
52-wk high
0,03 A$
52-wk low
0,01 A$
EPS
-0,01 A$
Shares outstanding
253,04 млн
News stories
From web sources and news partners
About Nexalis Therapeutics Ltd
CEO-
Employees-
Founded2016
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
217,49 м.
217,49 м.
315,05 м.
315,05 м.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
376,83 м.
376,83 м.
637,88 м.
637,88 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
182,51 м.
182,51 м.
235,88 м.
235,88 м.
Operating expense
559,06 м.
559,06 м.
903,79 м.
903,79 м.
Total operating expenses
559,06 м.
559,06 м.
903,79 м.
903,79 м.
Operating income
-341,56 м.
-341,56 м.
-588,73 м.
-588,73 м.
Other non operating income
-
-
-
-
EBT including unusual items
-382,22 м.
-382,22 м.
-648,97 м.
-648,97 м.
EBT excluding unusual items
-382,22 м.
-382,22 м.
-648,97 м.
-648,97 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-13,90 мың
-13,90 мың
29,15 мың
29,15 мың
Net income
-382,22 м.
-382,22 м.
-648,97 м.
-648,97 м.
Net profit margin
-175,74%
-175,74%
-205,99%
-205,99%
Earnings per share
-
-
-
-
Interest and investment income
32,00
32,00
537,00
537,00
Interest expense
-40,69 мың
-40,69 мың
-60,77 мың
-60,77 мың
Net interest expenses
-40,66 мың
-40,66 мың
-60,24 мың
-60,24 мың
Depreciation and amortization charges
-
-
877,00
877,00
EBITDA
-
-
-587,86 м.
-587,86 м.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары